The government has decidedwhich proposes to introduce a new drug reimbursement mechanism.
Currently, the beneficiaries of social or special groups of the population are allocated medicines with full or partial reimbursement of their costWith the adoption of the decision, it is envisaged that the beneficiaries who have the right to purchase drugs for free and on preferential terms will have the opportunity to directly purchase the drugs for the treatment or continuous maintenance of cardiovascular diseases chosen by them and suitable for them individually from the pharmacy.
